KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹33 Cr | ₹33 Cr | ₹33 Cr | ₹34 Cr | ₹40 Cr |
What is the latest Total Non-Current Liabilities ratio of KOPRAN ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹33 Cr |
Mar2023 | ₹33 Cr |
Mar2022 | ₹33 Cr |
Mar2021 | ₹34 Cr |
Mar2020 | ₹40 Cr |
How is Total Non-Current Liabilities of KOPRAN Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹33 Cr | -0.03 | |
Mar2023 | ₹33 Cr | 1.05 | |
Mar2022 | ₹33 Cr | -1.59 | |
Mar2021 | ₹34 Cr | -16.83 | |
Mar2020 | ₹40 Cr | - |
Compare Total Non-Current Liabilities of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹1,160.9 Cr | -24.9% | -19% | 26.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,914.0 Cr | -0.7% | -6.2% | 52.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,258.0 Cr | -3.1% | -5.5% | 66.2% | Stock Analytics | |
CIPLA | ₹121,563.0 Cr | -4.3% | -4.2% | 23% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,939.0 Cr | -3.2% | -5.9% | 16.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,960.7 Cr | -0.9% | -8.9% | 53.3% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | -24.9% |
-19% |
26.8% |
SENSEX | -3.3% |
-5.2% |
19.8% |
You may also like the below Video Courses